ONO PHARMACEUTICAL CO., LTD.

President and Representative Director: Gyo Sagara

Code No: 4528 at the 1st section of the Tokyo Stock Exchange Inquiries: Yukio Tani, Managing Director, Corporate Communications

June 13, 2017

Announcement on Acquisition and Retirement of Own Shares

(Acquisition of Own Shares under the Articles of Incorporation Provided in Article 165,Paragraph 2 of the Companies Act and Retirement of Own Shares Provided in Article 178 of Companies Act)

Osaka, Japan, June 13, 2017 - Ono Pharmaceutical Co., Ltd. (President, Representative Director and CEO, Gyo Sagara; "the Company") resolved at a meeting of the Board of Directors held today to acquire Own Shares under Article 156 of the Companies Act, applied by the reading of terms pursuant to the provisions of Paragraph 3, Article 165 of the Act. The Company also resolved to retire Own Shares pursuant to the provisions of Article 178 of the Companies Act.

Particulars

  1. Reasons for the acquisition and retirement of own shares

    The shares will be acquired for the purpose of improving capital efficiency and as a part of measures for shareholder return.

  2. Contents of the acquisition

    (1)

    Class of shares to be acquired:

    Common stock of the Company

    (2)

    Total number of shares to be acquired:

    Up to 20 million shares

    (The percentage compared to the total number of the

    shares issued excluding own shares: 3.77%)

    (3)

    Aggregate amount of acquisition cost:

    Up to ¥50.0 billion

    (4)

    Period of acquisition:

    From June 14, 2017 to September 29, 2017

    (5)

    Method for acquisition:

    Purchase on the Tokyo Stock Exchange

    (6)

    Schedule after acquisition:

    Acquired all the common stock will be retired

  3. Contents of the retirement

(1)

Class of shares to be retired:

Common stock of the Company

(2)

Total number of shares to be retired:

All the common stock acquired in accordance with

section 2 above and 30 million shares(Treasury stock

owned other than above 2).

(3)

Scheduled date of retirement:

October 31, 2017

(Reference)

The status of treasury shares as of March 31, 2017

Total number of shares issued (excluding treasury shares): 530,080,660 shares Total number of treasury shares: 59,156,840 shares

ONO Pharmaceutical Co. Ltd. published this content on 13 June 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 13 June 2017 07:04:27 UTC.

Original documenthttp://www.ono.co.jp/eng/news/pdf/sm_cn170613.pdf

Public permalinkhttp://www.publicnow.com/view/7588DC4640DB72C85395F40E18F1F3EB4D8BC28F